USPTO serial 78132364
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Fred Carl III
BAYER CORPORATION BAYER CORPORATION100 BAYER RDPITTSBURGH, PA 15205UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of sexual dysfunction, cardiovascular diseases, central nervous system diseases, cancer, respiratory and infectious diseases, diagnostics reagents adapted for medical use | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 17, 2003 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jan 10, 2003 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 3, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 26, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 2002 | DOCK | ASSIGNED TO EXAMINER | — |